The experience of flow cytometry for specific antibody against cisplatin-treated red blood cells: A case report.
Kazutaka SuzukiKeiki NagaharuMitsuko MaruyamaTakeshi MatsumotoKohshi OhishiIsao TawaraPublished in: Transfusion (2023)
Here, we report a rare case of a patient with hemolysis diagnosed using FCM to identify specific antibodies against cisplatin-treated RBCs. NIPA and immunological mechanisms may contribute to hemolysis onset during cisplatin treatment.